Brendan Saloner

Brendan Saloner, PhD, is a Bloomberg Professor of American Health at Johns Hopkins University, affiliated with the Bloomberg School of Public Health's Department of Health Policy and Management, the Berman Institute of Bioethics, and the Department of Mental Health. His research focuses on health equity, U.S. healthcare reform, and substance use disorder treatment. He holds a BA from UC Berkeley and a PhD in Health Policy from Harvard University, with a concentration in ethics.

Dr. Saloner's work examines Medicaid cost-sharing policies, mental health treatment disparities, and opioid epidemic responses. His research has been featured in New England Journal of Medicine, Health Affairs, and major media outlets. He has received prestigious awards including the Alice S. Hersh Emerging Leader Award (2019) and fellowships from the Robert Wood Johnson Foundation and National Academy of Medicine.

His recent studies address fentanyl's impact on older adults, opioid treatment in carceral settings, and harm reduction strategies. Key themes include policy innovations to reduce disparities in healthcare access and improving treatment retention for vulnerable populations.

• Education: BA (UC Berkeley), PhD (Harvard Health Policy)
• Awards: Alice S. Hersh Award (2019), RWJF Health & Society Scholar (2012-2014)

Saloner collaborates with policymakers and clinicians to translate evidence into actionable solutions, emphasizing ethical frameworks in healthcare financing and delivery.